(Q51659017)

English

The safety of autologous and metabolically fit bone marrow mesenchymal stromal cells in medically refractory Crohn's disease - a phase 1 trial with three doses.

scientific article published on 7 July 2016

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

9 April 2018

http://europepmc.org/abstract/MED/27385373

The safety of autologous and metabolically fit bone marrow mesenchymal stromal cells in medically refractory Crohn's disease - a phase 1 trial with three doses. (English)

1 reference

Europe PubMed Central

9 April 2018

http://europepmc.org/abstract/MED/27385373

phase I clinical trial

0 references

Crohn's disease

1 reference

based on heuristic

inferred from title

author name string

T Dhere

1

1 reference

Europe PubMed Central

9 April 2018

http://europepmc.org/abstract/MED/27385373

I Copland

2

1 reference

Europe PubMed Central

9 April 2018

http://europepmc.org/abstract/MED/27385373

M Garcia

3

1 reference

Europe PubMed Central

9 April 2018

http://europepmc.org/abstract/MED/27385373

K Y Chiang

4

1 reference

Europe PubMed Central

9 April 2018

http://europepmc.org/abstract/MED/27385373

R Chinnadurai

5

1 reference

Europe PubMed Central

9 April 2018

http://europepmc.org/abstract/MED/27385373

M Prasad

6

1 reference

Europe PubMed Central

9 April 2018

http://europepmc.org/abstract/MED/27385373

J Galipeau

7

1 reference

Europe PubMed Central

9 April 2018

http://europepmc.org/abstract/MED/27385373

S Kugathasan

8

1 reference

Europe PubMed Central

9 April 2018

http://europepmc.org/abstract/MED/27385373

language of work or name

0 references

publication date

7 July 2016

1 reference

Europe PubMed Central

9 April 2018

http://europepmc.org/abstract/MED/27385373

Alimentary Pharmacology & Therapeutics

1 reference

Europe PubMed Central

9 April 2018

http://europepmc.org/abstract/MED/27385373

44

1 reference

Europe PubMed Central

9 April 2018

http://europepmc.org/abstract/MED/27385373

5

1 reference

Europe PubMed Central

9 April 2018

http://europepmc.org/abstract/MED/27385373

471-481

1 reference

Europe PubMed Central

9 April 2018

http://europepmc.org/abstract/MED/27385373

Etiopathogenesis of inflammatory bowel disease: the importance of the pediatric perspective

1 reference

https://api.crossref.org/works/10.1111%2FAPT.13717

21 January 2018

Inflammatory bowel disease: epidemiology, pathogenesis, and therapeutic opportunities

1 reference

https://api.crossref.org/works/10.1111%2FAPT.13717

21 January 2018

Hepatosplenic T-cell lymphoma in adolescents and young adults with Crohn's disease: a cautionary tale?

1 reference

https://api.crossref.org/works/10.1111%2FAPT.13717

21 January 2018

Use of immunomodulators and biologic therapies in children with inflammatory bowel disease

1 reference

https://api.crossref.org/works/10.1111%2FAPT.13717

21 January 2018

Good manufacturing practices production of mesenchymal stem/stromal cells.

1 reference

https://api.crossref.org/works/10.1111%2FAPT.13717

21 January 2018

Global transcriptome analysis of human bone marrow stromal cells (BMSC) reveals proliferative, mobile and interactive cells that produce abundant extracellular matrix proteins, some of which may affect BMSC potency

1 reference

https://api.crossref.org/works/10.1111%2FAPT.13717

21 January 2018

Multipotent mesenchymal stromal cells and the innate immune system

1 reference

https://api.crossref.org/works/10.1111%2FAPT.13717

21 January 2018

Mesenchymal stem cells: environmentally responsive therapeutics for regenerative medicine

1 reference

https://api.crossref.org/works/10.1111%2FAPT.13717

21 January 2018

Autologous bone marrow-derived mesenchymal stromal cell treatment for refractory luminal Crohn's disease: results of a phase I study.

1 reference

https://api.crossref.org/works/10.1111%2FAPT.13717

21 January 2018

A phase 2 study of allogeneic mesenchymal stromal cells for luminal Crohn's disease refractory to biologic therapy.

1 reference

https://api.crossref.org/works/10.1111%2FAPT.13717

21 January 2018

Actin cytoskeletal disruption following cryopreservation alters the biodistribution of human mesenchymal stromal cells in vivo

1 reference

https://api.crossref.org/works/10.1111%2FAPT.13717

21 January 2018

Cryopreserved mesenchymal stromal cells display impaired immunosuppressive properties as a result of heat-shock response and impaired interferon-γ licensing

1 reference

https://api.crossref.org/works/10.1111%2FAPT.13717

21 January 2018

New insights on translational development of mesenchymal stromal cells for suppressor therapy

1 reference

https://api.crossref.org/works/10.1111%2FAPT.13717

21 January 2018

Casting doubt on the safety of "off-the-shelf" mesenchymal stem cells for cell therapy

1 reference

https://api.crossref.org/works/10.1111%2FAPT.13717

21 January 2018

The mesenchymal stromal cells dilemma--does a negative phase III trial of random donor mesenchymal stromal cells in steroid-resistant graft-versus-host disease represent a death knell or a bump in the road?

1 reference

https://api.crossref.org/works/10.1111%2FAPT.13717

21 January 2018

Mesenchymal Stromal Cells Derived From Crohn's Patients Deploy Indoleamine 2,3-dioxygenase-mediated Immune Suppression, Independent of Autophagy

1 reference

https://api.crossref.org/works/10.1111%2FAPT.13717

21 January 2018

Allogeneic Bone Marrow-Derived Mesenchymal Stromal Cells Promote Healing of Refractory Perianal Fistulas in Patients With Crohn's Disease.

1 reference

https://api.crossref.org/works/10.1111%2FAPT.13717

21 January 2018

Regulation of MHC class II expression and antigen processing in murine and human mesenchymal stromal cells by IFN-gamma, TGF-beta, and cell density

1 reference

https://api.crossref.org/works/10.1111%2FAPT.13717

21 January 2018

Treatment with mesenchymal stromal cells is a risk factor for pneumonia-related death after allogeneic hematopoietic stem cell transplantation

1 reference

https://api.crossref.org/works/10.1111%2FAPT.13717

21 January 2018

Internalized antigens must be removed to prepare hypoimmunogenic mesenchymal stem cells for cell and gene therapy

1 reference

https://api.crossref.org/works/10.1111%2FAPT.13717

21 January 2018

Identifiers

10.1111/APT.13717

1 reference

Europe PubMed Central

9 April 2018

http://europepmc.org/abstract/MED/27385373

1 reference

Europe PubMed Central

9 April 2018

http://europepmc.org/abstract/MED/27385373

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q51659017&oldid=1749508732"